PHILADELPHIA, PA — Bloom has launched its cannabis vape products in Pennsylvania’s medical marijuana market through a partnership with Cresco Labs (CSE: CL) (OTCQX: CRLBF), expanding its presence into one of the largest medical-only cannabis markets in the United States.
The launch marks Bloom’s second market entry with Cresco Labs, following a rollout in Florida dispensaries in December 2024.
Bloom’s products will be distributed through Cresco’s retail network in Pennsylvania, including Sunnyside dispensaries.
The company will introduce a selection of vape products, including its all-in-one Surf device and 510-thread cartridges, both in one-gram formats.
The initial rollout will feature strains from Bloom’s Live Collection, which are designed to deliver consistent dosing and repeatable effects for medical cannabis patients.
Pennsylvania’s medical cannabis market has seen widespread adoption of vape products among patients, according to the companies.
“Pennsylvania has one of the most established medical cannabis programs in the country, and patients here have already made vapes a primary format for patient use,” said Vitaly Mekk, Bloom’s founder and co-chief executive officer.
Cris Rivera, regional vice president at Cresco Labs, said the partnership aligns with demand for vape products in the state.
“With our established scale, Cresco Labs is positioned to bring partners like Bloom into this market,” Rivera said.
Bloom, founded in 2014 in California, develops cannabis vaporizer hardware and formulations and operates in multiple medical cannabis markets, including Florida and Virginia.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.